Effect of histamine and the H2 antagonist cimetidine on the growth and migration of human neoplastic glia

Neuropathology and Applied Neurobiology

Volumn 22, Issue 4, 1996, Pages 317-324

  Finn, P E ^a   Purnell, P ^a   Pilkington, G J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cimetidine; Glioma; Histamine; Migration

Indexed keywords

CIMETIDINE; CYCLINE; HISTAMINE; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR ANTAGONIST;

ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH; BRAIN TUMOR; CELL CULTURE; CELL CYCLE; CELL MOTION; CHEMICAL PHENOMENA; DRUG EFFECT; GLIA; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; ULTRASTRUCTURE; UPREGULATION;

BRAIN NEOPLASMS; CELL CYCLE; CELL MOVEMENT; CIMETIDINE; DEPRESSION, CHEMICAL; GLIOMA; HISTAMINE; HISTAMINE H2 ANTAGONISTS; HUMANS; IMMUNOHISTOCHEMISTRY; NEUROGLIA; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029658606     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb01110.x     Document Type: Article

References (21)

1. Armitage JO, Sidner RD. Antitumour effect of cimetidine? Lancet 1979; i: 882-3
2. Bartholeyns J, Bouclier M. Involvement of histamine in growth of mouse and rat tumours: antitumoural properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase. Cancer Res 1984; 44: 639-45
3. Bartholeyns J, Fozard JR. Role of histamine in tumour development. Trends Pharmacol Sci 1985; 7: 123-5
4. Black PMcL, Schoene WC, Lampson LA (Eds). Astrocytomas: Diagnosis, Treatment and Biology. Oxford: Blackwell Science, 1993
5. Gifford RRM, Ferguson RM, Voss BV. Cimetidine reduction of tumour proliferation in mice. Lancet 1981; i: 638-9
6. Kahlson G, Rosengren E. New approaches to the physiology of histamine. Physiol Rev 1968; 48: 155-96
7. Kornblith PL, Walker M. Chemotherapy for malignant gliomas. J Neurosurg 1988; 68: 1-6
8. Liebel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1988; 66: 1-8
9. Merzak A, Koochekpour S, Pilkington, GJ. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994a; 54: 3988-92
10. Merzak A, Koochekpour S, McCrea S, Roxanis Y, Pilkington GJ. Gangliosides modulate proliferation, migration, and invasion of human brain tumour cells in vitro. Mol Chem Neuropathol 1995; 24: 12
11. Moller H, Linding K, Klefter R, Mosbech J, Moller Jensen O. Cancer occurrence in a cohort of patients treated with cimetidine. Gut 1989; 30: 1558-62
12. Nomura T, Ikezaki K, Matsukado K, Fukui M. Effect of histamine on the blood-tumor barrier in transplanted rat brain tumors. Acta Neurochir Suppl. Wien 1994; 60: 400-2
13. Osband ME, Shon YE, Shlesinger M et al. Successful tumour immunotherapy with cimetidine in mice. Lancet 1981; i: 882-3
14. 1 receptors functionally coupled to phosphoinositide hydrolysis in C6 glioma cells: regulation by cyclic AMP. Br J Pharmacol 1994; 113: 1554-60
15. Pilkington GJ. Glioma heterogeneity in vitro: the significance of growth factors and gangliosides. Neuropath Appl Neurobiol 1992; 18: 434-42
16. Scotcher S, Sikova K, Freedman L. Gastric cancer and cimetidine: does delay in diagnosis matter? Lancet 1981; ii: 630-1
17. Shapiro JR, Yung WA, Shapiro WR. Isolation, karyotype and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res 1981; 41: 22-6
18. Small RK, Riddle P, Noble M. Evidence for migration of oligodendrocyte-type 2 astrocyte progenitor cells into developing rat optic nerve. Nature 1987; 328: 155-7
19. 2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun 1991; 177: 545-50
20. Van der Ven LTM, Prinsen IM, Jansen GH et al. Growth of cultured human glioma tumour cells can be regulated with histamine and histamine antagonists. Br J Cancer 1993; 68: 475-83
21. Wolff M, Baker DK. Immunohistochemical demonstration of immunoglobulins and albumin in human brain tumours. Clin Neuropathol 1989; 8: 72-8